Covid-19 Research

Letter to Editor

Use of Polio Vaccine Salk vs SARS- CoV-2E and HIV-1E 2, both as Therapeutic Drug and Effective Vaccine to Make Memory-Cells Able to Stop Reinfections

Journal of Biomedical Research & Environmental Sciences article abstract with citation details, DOI, publication dates, subject areas, full text links, and references.

View DOI Submit Manuscript

Article Details

Publication record, authors, dates, abstract, and full text access.

Open Access
Article Type Letter to Editor
Subject Biology Group
OCLC 8769661812
Raffaele Ansovini* and Leonardo Compagnucci
Issue: Volume1-Issue7
Pages: 311-312
Received: 2020-11-16
Accepted: 2020-11-17
Published: 2020-11-18

Abstract

Dr. Ansovini began studying viruses by focusing his attention on HIV-1. The main discovery he made is that this virus, so difficult to treat, can be classified as “electrical”: one of its functional proteins, i.e. “p. 24”, actually has an electrical value, in other words it has a charge, and therefore it is not allosterically neutral as proteins usually are.

FullText HTML FullText PDF DOI: 10.37871/jbres1160 Crossmark

Certificate of Publication

Certificate of Publication

Copyright

© 2020 Ansovini R, et al. Distributed under Creative Commons CC-BY 4.0 Creative CommonsAttribution

How to cite this article

Ansovini R, Compagnucci L. Use of Polio Vaccine Salk vs SARS- CoV-2E and HIV-1E 2, both as Therapeutic Drug and Effective Vaccine to Make Memory-Cells Able to Stop Reinfections. J Biomed Res Environ Sci. 2020 Nov 18; 1(7): 311-312. doi: 10.37871/jbres1160, Article ID: jbres1160

Subject area(s)

Drug MetabolismBiologyVirology

References

No references available.

Publish with JBRES — Peer-reviewed, multidisciplinary Open Access with rapid review, DOI, and global visibility.
Double-Blind CrossRef DOI Discoverable
Submit Manuscript Membership